Pharmacological modulation of positive ampa receptor...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5365 (2006.01) A61K 31/4168 (2006.01) A61K 31/42 (2006.01) A61K 31/44 (2006.01) A61K 31/4439 (2006.01) A61K 45/06 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2649844

Antagonists of group 1 metabotropic glutamate receptors (mGluR) potentiate the effect of positive AMPA receptor modulators on neurotrophin expression, such as brain-derived neurotrophic factor (BDNF). The findings described herein suggest a combinatorial approach for drug therapies, using both positive AMPA receptor modulators and mGluR antagonists, to enhance brain neurotrophism.

Selon l'invention, les antagonistes des récepteurs métabotropiques du glutamate (mGluR) du groupe 1 potentialisent l'effet positif des modulateurs des récepteurs AMPA sur l'expression de neurotrophines telles que le facteur neurotrophique dérivé du cerveau (BDNF). Les découvertes décrites dans la présente invention suggèrent pour les thérapies médicamenteuses une approche combinatoire utilisant à la fois des modulateurs positifs des récepteurs AMPA et des antagonistes des récepteurs mGluR pour renforcer le neurotropisme cérébral.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmacological modulation of positive ampa receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmacological modulation of positive ampa receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacological modulation of positive ampa receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1633984

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.